Pharm Nitrous - Lecture 5 – Pharmacology of Nitrous Oxide

Chemical identity and terminology

• Nitrous oxide official chemical name: dinitrogen monoxide
• Chemical formula: $N_2O$
• Common confusion to avoid in documentation:
  • Not $NO_2$ (nitrogen dioxide, a pollutant)
  • Not $NO$ (nitric oxide)
• Importance in records: write the correct chemical name and formula to avoid legal/medical chart issues when documenting nitrous oxide administration.
• Common exam question: chemical formula is $N_2O$; students often miss it.

Basic properties and physical behavior

• Molecular weight: $MW = 44 \, g/mol$
• Boiling point at 1 atm: $T_b = -88^ ext{°C}$
• At room temperature, nitrous oxide is a gas, but it can be stored as a liquid under pressure below its critical temperature.
• In use, the tank contains liquid nitrous oxide with gas phase above it; as gas leaves under pressure, liquid converts to gas to maintain vapor pressure.
• Vapor pressure at 20°C: approximately $P_{vap}(20^ ext{°C}) \approx 760-800 \, psi$
• When the tank is opened fully, adiabatic cooling can occur, leading to frost formation at the outlet/connections.
• Frost can also appear on components if there is a leak or high flow in some conditions.

Production, purity, and contaminants

• Manufacturing process: ammonium nitrate heated to ~$240^ ext{°C}$ yields nitrous oxide and water.
• If heated above ~$450^ ext{°C}$, nitric oxide forms, which is undesirable to inhale.
• Major medical-grade nitrous oxide purity: >$97\%$, typically around $99.5\%$ after purification (impurities scrubbed).
• Major contaminant in medical-grade gas: nitrogen gas (N₂) is the principal benign contaminant since nitrogen is common in air (~78%).
• Non-medical (industrial) nitrous oxide can contain contaminants such as nitric oxide, nitrogen dioxide, ammonia, carbon monoxide, etc.; avoid using restaurant/industrial grades for medical use.
• Anhydrous nature: nitrous oxide is dry (no water vapor) to prevent water vapor from freezing at the reducing valve and causing pressure/flow issues.
• Anecdote: a major producer in the environment is earthworms (a humorous aside).

Medical-grade vs non-medical grade and safety implications

• Medical-grade nitrous oxide must be >$97\%$ pure; in practice ~$99.5\%$ pure after purification.
• Contaminants in non-medical grade: nitric oxide, nitrogen dioxide, ammonia, carbon monoxide, etc.; these pose substantial health risks.
• Safety note: use only medical-grade gas for patient care to avoid toxic impurities.

Physical perception and patient experience

• Nitrous oxide is colorless and odorless.
• It is also described as dry (anhydrous) and non-irritating; at higher concentrations, mucosa may feel very dry.
• Because of its non-irritant nature, it does not provoke coughing or bronchospasm at high concentrations.

Solubility, onset, and pharmacokinetics (why it acts quickly)

• Blood-gas partition coefficient: $P_{B/g} = 0.47$ (low solubility in blood)
• Consequence: fast onset and very fast offset of action.
• Comparison example: highly soluble gases (e.g., ether) have higher $P_{B/g}$ (e.g., around $12.1$), leading to slower onset.
• Conceptual demonstration used in class: a visual analogy with sugar vs sand in warm water to illustrate solubility and onset:
  • Two glasses represent the body; bottom is the brain.
  • Soluble drug (sugar) vs insoluble drug (sand) in water correspond to slower vs faster brain uptake.
  • Nitrous oxide behaves as the insoluble (sand) analogy, delivering rapid brain exposure and fast onset.
• Practical implication: because nitrous oxide is very insoluble, it reaches peak effect quickly and reverses quickly when the gas is removed, allowing rapid titration and quick return to baseline.
• Onset/offset takeaway: fast onset and offset make nitrous oxide unique among sedatives in its ability to allow prompt return to baseline after administration.
• In clinical practice, this property enables titration to the desired effect and potential for the patient to drive home after adequate recovery if no other depressants are used.

Dose ranges, sedation levels, and clinical targets

• Typical sedative range: roughly $30-40\%$ nitrous oxide (rest is oxygen) for minimal sedation.
• Anesthetic range: around $70\%$ nitrous oxide with the balance oxygen; not a true general anesthetic because MAC for nitrous oxide is around or above 1.04 (104%), which means you cannot achieve full MAC in practice with N₂O alone.
• Practical notes:
  • Lower levels: mild to moderate sedation and analgesia, with dose-related effects appearing.
  • Higher levels (e.g., >50% N₂O): deeper sedation with potential unconsciousness in some patients.
  • The machine and monitoring should prevent hypoxia; most delivery units are designed so that hypoxia is unlikely when using typical ranges (e.g., not exceeding ~70% N₂O).
• At higher proportions (50-60%+ N₂O), there is increased risk of amnesia, nausea, vomiting, and other adverse effects.

Mechanisms of action and pharmacodynamics

• Primary CNS effects: main rationale for use is mild sedation and anxiolysis, with some analgesia.
• Receptors and pathways:
  • NMDA receptor antagonism contributing to analgesia and sedative effects.
  • GABA receptor interactions contributing to anxiolysis and sedation.
  • Endogenous opioid peptide release potentially stimulated by nitrous oxide.
• Analgesia and opioid interaction:
  • Analgesia is dose-related and can be substantial at higher concentrations.
  • Naloxone (an opioid antagonist) can block the analgesic effect but not the sedative effect, suggesting analgesia is mediated via endogenous opioids.
  • Flumazenil (benzodiazepine receptor antagonist) can reverse some of the sedative effects, indicating GABAergic involvement.
• Putative molecular model (simplified):
  • Arginine uptake and conversion to nitric oxide via NOS may contribute to signaling that promotes endogenous opioid release, which then acts on postsynaptic opioid receptors to produce analgesia.
  • The diagrammatic pathway illustrates release and postsynaptic activation as part of the analgesic mechanism.

Cardiovascular effects

• At sedative levels: minor changes in blood pressure and heart rate; typically mild.
• At anesthetic concentrations: direct myocardial depressant effects; potential moderate decreases in blood pressure and heart rate.
• Hemodynamic response during titration:
  • In anxious patients, nitrous oxide can reduce elevated heart rate and blood pressure as sedation takes effect.
  • At lower concentrations, cutaneous vasodilation may occur, aiding venous visualization for IV placement.
  • At higher concentrations, sympathetic tone may increase to offset myocardial depression and maintain cardiac output.
• Overall cardiac output: nitrous oxide has little influence on arterial pressure at common sedative levels; very mild effects on cardiac output at low to moderate exposures; with opioids or other depressants, effects can be more pronounced due to interactions.
• Interactions with other drugs:
  • When combined with opioids, depressant effects on the cardiovascular system may be amplified; titration and monitoring are essential.

Respiratory effects

• Sedative levels: mild increase in respiratory rate.
• Anesthetic levels: decreased responsiveness to increases in CO₂ (reduced drive to breathe).
• Protective reflexes: generally intact at sedative levels (cough, swallow, gag) except gag reflex can be diminished at higher levels.
• Gag reflex: preserved at sedative levels; can be blunted at anesthesia levels, allowing use in patients needing dental procedures where gagging is a problem.
• Ventilatory drive:
  • Nitrous oxide tends to increase minute ventilation due to higher respiratory rate with a potentially smaller tidal volume, leading to net changes in ventilation.
  • Compared to other inhalation anesthetics (e.g., halothane, isoflurane, sevoflurane, etc.), nitrous oxide has a milder depressive effect on ventilation at sedative levels.
• Oxygenation: with the typical delivery mix (nitrous oxide balanced with oxygen), there is no hypoxia when used within recommended ranges; machines include safety systems to help prevent hypoxia.
• Protective limits: in practice, nitrous oxide delivery is designed to avoid hypoxia; exceeding 70% N₂O in the mix is discouraged due to oxygen depletion risk.

Sensory-sensory and perceptual effects

• At 72% concentration (approximate peak sedative-to-anesthetic range in the lecture): regular breathing with occasional deep breaths to blow off CO₂; breathing remains generally adequate.
• At higher anesthetic levels, breathing becomes irregular; gag, cough, and other reflex responses decline.
• Subjective effects at various doses:
  • Early stage (10–20% N₂O): warmth, tingling in hands/feet, and some guided imagery to help patients cope.
  • Mid-range (20–40% N₂O): analgesia begins; lips tingling; sensation of warmth and flow; some people feel like their body is melting into the chair; increased perceived euphoria and social connectedness.
  • Higher range (40–60% N₂O): dream-like state, possible mild hallucinations; some patients become very sleepy or disoriented; potential for amnesia at high doses but not universal.
  • Very high range (60–70% N₂O and beyond): possible profound analgesia, potential for unresponsiveness, uncoordination, and strong sedation; risk of nausea and vomiting increases with higher doses.
• Visual and auditory changes: sounds can seem muffled or altered; voices may sound strange due to changes in vocal resonance caused by the dry, non-humidified gas.
• Patient safety and behavior: always have an assistant when using higher doses to prevent misinterpretation or unsafe situations (e.g., allegations of inappropriate conduct); gradual titration is critical to avoid disorientation and to maintain patient cooperation.

Amnesia and cognitive effects

• Amnesia is possible at higher doses but is not guaranteed; memory of events can be unreliable at higher sedation levels.
• At lower sedation levels, there is typically no amnesia; patients remember events like procedures or discomforts present during the experience.

Gag reflex, protection, and dental practicality

• Gag reflex is a protective reflex, but its suppression at higher nitrous oxide levels can be advantageous for dental procedures requiring limited gagging.
• For patients with problematic gag reflexes, nitrous oxide can facilitate dental impressions, radiographs, and other procedures by reducing gagging, provided the patient remains adequately sedated and monitored.

Clinical monitoring, safety, and dosing strategy

• Titration strategy: start low (e.g., 10–20%), assess patient response, then increase gradually to the right level for comfort and analgesia; avoid rapid dosing to reduce adverse effects.
• Signs of adequate sedation/happy spot: patient feels calm, relaxed, in a state of euphoria or contentment, not out of control; questions and conversation should be coherent but slowed or softened; pain relief should be present.
• Signs of under- or over-sedation: inability to follow commands, unresponsiveness, or falling asleep indicates over-sedation; agitation or distress may indicate under-sedation or pain.
• Safety and monitoring: ensure airway patency; monitor breathing, circulation, and level of consciousness; be aware of potential airway compromise if the patient becomes unconscious and stops breathing normally.
• Consciousness and dependence: at sedative levels, patients are typically conscious but relaxed; at higher levels, risk of unconsciousness increases, mandating discontinuation or reduction of the gas and supportive care.

Practical clinical considerations and anecdotes

• Anecdotes from clinical settings:
  • Venice clinic: frost on nitrous oxide lines; a leak caused by external work near the unit; once fixed, frost disappeared.
  • Frost formation is a visual cue of adiabatic cooling and high flow through narrow outlets.
• Real-world production note: nitrous oxide supply can be affected by plant issues; a temporary shortage occurred due to plant problems in Florida; this highlights the dependence on specialized facilities for production.
• Safety note about female patients: caution about potential misinterpretations or allegations if an interaction is misconstrued; ensure presence of an assistant to provide safeguarding and auditing.

Summary of practical guidelines

• Use medical-grade nitrous oxide with high purity (preferably >97\%, ideally around $99.5\%$) and with clean, dry gas.
• Keep the oxygen fraction at safe, effective levels; avoid exceeding approximately $70\%$ nitrous oxide to minimize hypoxia risk; monitor gas mix and equipment safety features.
• Employ slow, deliberate titration to reach the “happy place” (sedation balance) without overshooting into deep sedation or amnesia.
• Be mindful of individual variability: some patients may experience tingling, warmth, euphoria, or dream-like states at different doses; some patients may tolerate higher doses without many effects.
• Monitor for adverse effects: nausea, vomiting, disorientation, amnesia, excessive drowsiness, and airway compromise if patient becomes unresponsive.
• Recognize interactions: analgesia can be opioid-mediated and can be blocked by naloxone (blocks analgesia but not sedation); sedation can be reversed by flumazenil (benzodiazepine receptor antagonist).
• Prepare for potential behavioral issues or misunderstandings by never with a single operator administering high dosages; ensure an assistant is present.
• Use the device’s safety features that regulate oxygen delivery and minimize the risk of hypoxia; understand that the anesthetic effects are not equivalent to full general anesthesia, even at high concentrations.

Key numerical and reference values (recap)

• Chemical formula: $N_2O$
• Molecular weight: $MW = 44 \text{ g/mol}$
• Boiling point: $T_b = -88^\circ\text{C}$
• Vapor pressure at 20°C: $P_{vap} \approx 760-800\ \text{psi}$
• Blood-gas partition coefficient: $P_{B/g} = 0.47$
• Mechanistic receptor involvement: NMDA antagonism; GABAergic modulation; endogenous opioids;
  possible NO-mediated signaling.
• Typical sedation range: $\approx 30-40\%$ N₂O (balance is oxygen).
• Higher (anesthetic) range: $\approx 70\%$ N₂O (balance oxygen).
• MAC note: Nitrous oxide MAC about $1.04\; (104\%)$; cannot achieve true MAC with N₂O alone; practical use relies on titration and safety features.
• Hypoxia risk: minimal when used with appropriate equipment; safety systems limit maximum N₂O concentration in practice.
• Speed of onset/offset: very rapid due to low solubility; allows quick recovery after cessation.